Elevance Health (ELV) had its price target lowered by Robert W. Baird from $340.00 to $317.00. They now have a "neutral" rating on the stock.
ELV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Elevance Health (ELV) had its price target lowered by Truist Financial Corporation from $390.00 to $375.00. They now have a "buy" rating on the stock.
Elevance Health (ELV) is now covered by Evercore Inc. They set an "in-line" rating and a $345.00 price target on the stock.
BofA Updates Managed Care Outlook, Raises Elevance Health (ELV) Price Target [Yahoo! Finance]